ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
gavreto
roche registration gmbh - pralsetinib - carcinom, pulmonar non-celulă mică - agenți antineoplazici - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.
ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
lunsumio
roche registration gmbh - mosunetuzumab - limfom, folicular - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.
ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - oftalmologice - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
ইউরোপীয় ইউনিয়ন -
রোমানীয় -
EMA (European Medicines Agency)
columvi
roche registration gmbh - glofitamab - lymphoma, large b-cell, diffuse - agenți antineoplazici - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.
মোল্দাভিয়া -
রোমানীয় -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
ocrevus 300 mg/10 ml concentrat pentru soluţie perfuzabilă
f.hoffmann-la roche, ltd. - ocrelizumab - concentrat pentru soluţie perfuzabilă - 300 mg/10 ml
মোল্দাভিয়া -
রোমানীয় -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
pulmozyme 2500 u/2,5 ml soluţie de inhalat prin nebulizator
f.hoffmann-la roche, ltd. - dornase alfa - soluţie de inhalat prin nebulizator - 2500 u/2,5 ml
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
casirivimab/imdevimab 120 mg/ml +120 mg/ml concentrat pentru solutie perfuzabila
roche registration gmbh - germania - casirivimabum+imdevimabum - conc. pt. sol. perf. - 120mg/ml+120mg/ml
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
madopar depot
roche pharma ag - germania - combinatii (levodopum+benserazidum) - caps. elib. modif. - 100mg+25mg - agenti dopaminergici dopa si derivati
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
alecensa 150mg
roche pharma ag - germania - alectinib - caps. - 150mg - inhibitori de protein-kinaza
রুমানিয়া -
রোমানীয় -
ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)
avastin 25mg/ml
roche pharma ag - germania - bevacizumabum - conc. pt. sol. perf. - 25mg/ml - anticorpi monoclonali si conjugati anticorp medicament inhibitori vegf/vegfr